Viewing Study NCT01927705

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:21 AM
Ignite Modification Date: 2025-12-26 @ 2:00 AM
Study NCT ID: NCT01927705
Status: COMPLETED
Last Update Posted: 2016-10-06
First Post: 2013-08-20
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis (AD)
Sponsor: Kang Stem Biotech Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Atopic Dermatitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Atopic dermatitis View
None Stem cell View
None Cell therapy View
None skin disease View
None furestem View
None AD View
None hUCB-MSC View
None UCB-MSC View
None Umbilical cord Blood View